FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Guus Rimmelzwaan

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Physiology

Virus Replication

Procedures

Vaccination

Co-author Network

Publications

TOP 3
Roelof A de Paus; Sangkot Marzuki; Tom H M Ottenhoff; Guus F Rimmelzwaan; Edhyana Sahiratmadja; Ruud van Beek; Reinout van Crevel; Alisjahbana Bachti; Jaap T van Dissel; Esther van de Vosse
The influence of influenza virus infections on the development of tuberculosis.
Rogier Bodewes; Ron A M Fouchier; Marine L B Hillaire; Joost H C M Kreijtz; Thijs Kuiken; Nella J Nieuwkoop; Albert D M E Osterhaus; Geert van Amerongen; Peter van Run; Stella E Vogelzang-van Trierum; Guus F Rimmelzwaan
Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.
Fatma Berri; Eric Camerer; Peter Carmeliet; Marie-Laure Foucault-Grunenwald; Patrica Gil; Michel Hanss; Vuong B Lê; Roger Lijnen; Bruno Lina; Dominique Martinez; Guus F Rimmelzwaan; Emmanuel Albina; Stella E Vogelzang-van Trierum; Béatrice Riteau
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Guus Rimmelzwaan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Roelof A de Paus; Sangkot Marzuki; Tom H M Ottenhoff; Guus F Rimmelzwaan; Edhyana Sahiratmadja; Ruud van Beek; Reinout van Crevel; Alisjahbana Bachti; Jaap T van Dissel; Esther van de Vosse
The influence of influenza virus infections on the development of tuberculosis.
Tuberculosis (Edinburgh, Scotland) 2013;93(3):338-42.
2013: Rogier Bodewes; Ron A M Fouchier; Marine L B Hillaire; Joost H C M Kreijtz; Thijs Kuiken; Nella J Nieuwkoop; Albert D M E Osterhaus; Geert van Amerongen; Peter van Run; Stella E Vogelzang-van Trierum; Guus F Rimmelzwaan
Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.
Journal of virology 2013;87(8):4293-301.
2013: Fatma Berri; Eric Camerer; Peter Carmeliet; Marie-Laure Foucault-Grunenwald; Patrica Gil; Michel Hanss; Vuong B Lê; Roger Lijnen; Bruno Lina; Dominique Martinez; Guus F Rimmelzwaan; Emmanuel Albina; Stella E Vogelzang-van Trierum; Béatrice Riteau
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.
PLoS pathogens 2013;9(3):e1003229.
2013: Marine L B Hillaire; Joost H C M Kreijtz; Albert D M E Osterhaus; Gerrie de Mutsert; Ron A M Fouchier; Stella E Vogelzang-van Trierum; Guus F Rimmelzwaan
Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
The Journal of general virology 2013;94(Pt 3):583-92.
2013: Lieke S Kamphuis; King H Lam; Guus F Rimmelzwaan; H Bing Thio; P L A van Daele; P Martin van Hagen; G Seerp Baarsma; Manou R Batstra; Willem A Dik; Mirjam E van Velthoven; Menno C van Zelm; Jan A van Laar
Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?
American journal of respiratory and critical care medicine 2013;187(4):406-16.
2013: Khaled Khoufache; Bruno Lina; Stephan Ludwig; Wolfgang Nacken; Oliver Planz; Guus F Rimmelzwaan; Fatma Berri; Eric Camerer; Peter Carmeliet; Shaun R Coughlin; Marie Delenne; Annette B Vogel; Béatrice Riteau
PAR1 contributes to influenza A virus pathogenicity in mice.
The Journal of clinical investigation 2013;123(1):206-14.
2013: Eefje J A Schrauwen; Theo M Bestebroer; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan; Sander Herfst
Reassortment between Avian H5N1 and human influenza viruses is mainly restricted to the matrix and neuraminidase gene segments.
PloS one 2013;8(3):e59889.
2013: Marine L B Hillaire; Nella J Nieuwkoop; Albert D M E Osterhaus; Adrianus C M Boon; Gerrie de Mutsert; Ron A M Fouchier; Stella E Vogelzang-van Trierum; Guus F Rimmelzwaan
Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells.
PloS one 2013;8(2):e56164.
2013: Marine L B Hillaire; Albert D M E Osterhaus; Guus F Rimmelzwaan; Henk P Haagsman; Martin van Eijk
Pulmonary Surfactant Protein D in First-Line Innate Defence against Influenza A Virus Infections.
Journal of innate immunity 2013;5(3):197-208.
2013: Elisabeth G W Huijskens; Erwin de Bruin; Menno D De Jong; Ingrid H M Friesema; Adam Meijer; Paul G H Mulder; Marcel F Peeters; Johan H J Reimerink; Guus F Rimmelzwaan; John W A Rossen; Janko van Beek; Marion Koopmans
Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.
PloS one 2013;8(1):e54890.
2012: Maryam Amidi; Volkert de Bot; Anna L de Goede; Rob A Gruters; Anastasia Lanzi; Guus F Rimmelzwaan; Marijn Schouten; Alice J A M Sijts; Neda Rafiei Tabataei; Mary J G van Helden; Enrico Mastrobattista
Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes.
Journal of controlled release : official journal of the Controlled Release Society 2012;164(3):323-30.
2012: Rogier Bodewes; Ron A M Fouchier; Pieter L A Fraaij; Martina M Geelhoed-Mieras; Joost H C M Kreijtz; Albert D M E Osterhaus; Guus F Rimmelzwaan
Annual influenza vaccination affects the development of heterosubtypic immunity.
Vaccine 2012;30(51):7407-10.
2012: Marine L B Hillaire; Nella J Nieuwkoop; Albert D M E Osterhaus; Ron A M Fouchier; Henk P Haagsman; Martin van Eijk; Stella E Vogelzang-van Trierum; Guus F Rimmelzwaan
The number and position of N-linked glycosylation sites in the hemagglutinin determine differential recognition of seasonal and 2009 pandemic H1N1 influenza virus by porcine surfactant protein D.
Virus research 2012;169(1):301-5.
2012: Carolien E van de Sandt; Joost H C M Kreijtz; Guus F Rimmelzwaan
Evasion of influenza A viruses from innate and adaptive immune responses.
Viruses 2012;4(9):1438-76.
2012: Kim B Westgeest; Theo M Bestebroer; Miranda de Graaf; Jan C de Jong; Mathieu Fourment; Albert D M E Osterhaus; Guus F Rimmelzwaan; Colin A Russell; Derek J Smith; Gavin J D Smith; Monique I J Spronken; R H T Van Beek; Ron A M Fouchier
Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution.
The Journal of general virology 2012;93(Pt 9):1996-2007.
2012: Rogier Bodewes; Pieter L A Fraaij; Albert D M E Osterhaus; Guus F Rimmelzwaan
Pediatric influenza vaccination: understanding the T-cell response.
Expert review of vaccines 2012;11(8):963-71.
2012: R Bodewes; R A M Fouchier; Nella J Nieuwkoop; A D M E Osterhaus; R J Verburgh; Guus F Rimmelzwaan
Use of influenza A viruses expressing reporter genes to assess the frequency of double infections in vitro.
The Journal of general virology 2012;93(Pt 8):1645-8.
2012: Sander Herfst; Martin Linster; Vincent J Munster; Albert D M E Osterhaus; Guus F Rimmelzwaan; Eefje J A Schrauwen; Derek J Smith; Erin M Sorrell; Theo M Bestebroer; david burke; Salin Chutinimitkul; Emmie de Wit; Ron A M Fouchier
Airborne transmission of influenza A/H5N1 virus between ferrets.
Science (New York, N.Y.) 2012;336(6088):1534-41.
2012: Laurens P Kil; Guus F Rimmelzwaan; Friedrich Thaiss; Jan Piet Van Hamburg; Pieter Fokko Van Loo; Menno van Nimwegen; Odilia B J Corneth; Marjolein J W de Bruijn; Dianne Delsing; Gemma M Dingjan; Dirk Elewaut; Rudi W Hendriks
Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice.
Blood 2012;119(16):3744-56.
2012: Eefje J A Schrauwen; Peter van Run; Theo M Bestebroer; Rogier Bodewes; Ron A M Fouchier; Sander Herfst; Joost H C M Kreijtz; Thijs Kuiken; Lonneke M Leijten; Martin Linster; Albert D M E Osterhaus; Guus F Rimmelzwaan; Debby van Riel
The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets.
Journal of virology 2012;86(7):3975-84.
2012: Guus F Rimmelzwaan
Developing vaccines against virus infections: between hope and fear.
Human vaccines & immunotherapeutics 2012;8(3):286-8.
2012: Patrick M Smit; Paul H M Smits; Eric C M van Gorp; Mohamed Ahdi; Stanley Darma; Ron Gerritsen; Jan W Mulder; Guus F Rimmelzwaan; Chris Roggeveen; Dees P M Brandjes
Low attack rate of novel influenza A (H1N1) virus infection among healthcare workers: a prospective study in a setting with an elaborated containment plan.
International archives of occupational and environmental health 2012;85(2):163-70.
2012: Josanne H Verhagen; Oanh Vuong; Pascal Lexmond; Frank Majoor; Vincent J Munster; Albert D M E Osterhaus; Guus F Rimmelzwaan; Martin Schutten; Roy Slaterus; Job B G Stumpel; Ron A M Fouchier
Avian influenza a virus in wild birds in highly urbanized areas.
PloS one 2012;7(6):e38256.
2011: J H C M Kreijtz; R A M Fouchier; Guus F Rimmelzwaan
Immune responses to influenza virus infection.
Virus research 2011;162(1-2):19-30.
2011: M L B Hillaire; M P Koopmans; A D M E Osterhaus; R Bodewes; R A M Fouchier; Carel A van Baalen; RS van Binnendijk; S E van Trierum; Guus F Rimmelzwaan
Characterization of the human CD8⁺ T cell response following infection with 2009 pandemic influenza H1N1 virus.
Journal of virology 2011;85(22):12057-61.
2011: Rogier Bodewes; Ron A M Fouchier; Pieter L A Fraaij; Martina M Geelhoed-Mieras; Albert D M E Osterhaus; Harm A W M Tiddens; Carel A van Baalen; Fiona R van der Klis; Annemarie M C van Rossum; Guus F Rimmelzwaan
Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.
Journal of virology 2011;85(22):11995-2000.
2011: Guus F Rimmelzwaan; Rogier Bodewes; Albert D M E Osterhaus
Vaccination strategies to protect children against seasonal and pandemic influenza.
Vaccine 2011;29(43):7551-3.
2011: Pieter L A Fraaij; Albert D M E Osterhaus; Rogier Bodewes; Guus F Rimmelzwaan
The ins and outs of universal childhood influenza vaccination.
Future microbiology 2011;6(10):1171-84.
2011: Marine L B Hillaire; Joost H C M Kreijtz; Thijs Kuiken; Nella J Nieuwkoop; Albert D M E Osterhaus; Rogier Bodewes; Ron A M Fouchier; Martina M Geelhoed-Mieras; Stella E van Trierum; Guus F Rimmelzwaan
Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells.
The Journal of general virology 2011;92(Pt 10):2339-49.
2011: Rogier Bodewes; Ron A M Fouchier; Joost H C M Kreijtz; Albert D M E Osterhaus; Guus F Rimmelzwaan; Geert van Amerongen; Thijs Kuiken
Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation.
The American journal of pathology 2011;179(1):30-6.
2011: Eefje J A Schrauwen; Theo M Bestebroer; Vincent J Munster; Elzo de Wit; Sander Herfst; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Insertion of a multibasic cleavage site in the haemagglutinin of human influenza H3N2 virus does not increase pathogenicity in ferrets.
The Journal of general virology 2011;92(Pt 6):1410-5.
2011: Guus F Rimmelzwaan; R Joyce Verburgh; Nella J Nieuwkoop; Theo M Bestebroer; Ron A M Fouchier; Albert D M E Osterhaus
Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies.
Vaccine 2011;29(18):3424-30.
2011: R Bodewes; J H C M Kreijtz; Martina M Geelhoed-Mieras; Geert van Amerongen; R J Verburgh; S E van Trierum; Thijs Kuiken; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.
Journal of virology 2011;85(6):2695-702.
2011: R Bodewes; Gerrie de Mutsert; F R M van der Klis; M Ventresca; S Wilks; Derek J Smith; Marion Koopmans; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.
Clinical and vaccine immunology : CVI 2011;18(3):469-76.
2011: Judith van den Brand; Joost H C M Kreijtz; Rogier Bodewes; Koert J Stittelaar; Geert van Amerongen; Thijs Kuiken; James Simon; Ron A M Fouchier; Giuseppe Del Giudice; Rino Rappuoli; Guus F Rimmelzwaan; Albert D M E Osterhaus
Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets.
Journal of virology 2011;85(6):2851-8.
2011: Eefje J A Schrauwen; Sander Herfst; Salin Chutinimitkul; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Thijs Kuiken; Ron A M Fouchier
Possible increased pathogenicity of pandemic (H1N1) 2009 influenza virus upon reassortment.
Emerging infectious diseases 2011;17(2):200-8.
2011: Frederika Dijkstra; Gé A Donker; Marcel Jonges; Marion Koopmans; Albert D M E Osterhaus; Guus F Rimmelzwaan; François G Schellevis; Ruud van Beek; Marianne A B van der Sande; Charles A B Boucher; Adam Meijer
Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008.
The open virology journal 2011;5():154-62.
2011: Marine L B Hillaire; Albert D M E Osterhaus; Guus F Rimmelzwaan
Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.
Journal of biomedicine & biotechnology 2011;2011():939860.
2011: Marine L B Hillaire; Thijs Kuiken; Albert D M E Osterhaus; Roland A Romijn; Xavier Saelens; Martin van Eijk; Debby van Riel; Stella E van Trierum; Ron A M Fouchier; Henk P Haagsman; Wieger Hemrika; Guus F Rimmelzwaan
Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitro.
PloS one 2011;6(9):e25005.
2011: Byron E E Martina; Petra van den Doel; Penelope Koraka; Geert van Amerongen; Gunther Spohn; Bart L Haagmans; Lisette B V Provacia; Albert D M E Osterhaus; Guus F Rimmelzwaan
A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.
PloS one 2011;6(4):e18995.
2011: Darius Soonawala; Guus F Rimmelzwaan; Luc B S Gelinck; Leo G Visser; Frank P Kroon
Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.
PloS one 2011;6(1):e16496.
2011: R Bodewes; Martina M Geelhoed-Mieras; Nella J Nieuwkoop; J A Hanson; C S David; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.
Virus research 2011;155(1):123-30.
2010: Debby van Riel; Guus F Rimmelzwaan; Geert van Amerongen; Albert D M E Osterhaus; Thijs Kuiken
Highly pathogenic avian influenza virus H7N7 isolated from a fatal human case causes respiratory disease in cats but does not spread systemically.
The American journal of pathology 2010;177(5):2185-90.
2010: Salin Chutinimitkul; Sander Herfst; John Steel; Anice C Lowen; Jianqiang Ye; Debby van Riel; Eefje J A Schrauwen; Theo M Bestebroer; Björn Koel; david burke; Kyle H Sutherland-Cash; Chris S Whittleston; Colin A Russell; David J Wales; Derek J Smith; Marcel Jonges; Adam Meijer; Marion Koopmans; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Adolfo García-Sastre; Daniel R Perez; Ron A M Fouchier
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding.
Journal of virology 2010;84(22):11802-13.
2010: Joost H C M Kreijtz; Yasemin Süzer; Rogier Bodewes; Astrid Schwantes; Geert van Amerongen; R Joyce Verburgh; Gerrie de Mutsert; Judith van den Brand; Stella E van Trierum; Thijs Kuiken; Ron A M Fouchier; Albert D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model.
The Journal of general virology 2010;91(Pt 11):2745-52.
2010: Fanny LeBouder; Bruno Lina; Guus F Rimmelzwaan; Béatrice Riteau
Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase.
The Journal of general virology 2010;91(Pt 11):2753-61.
2010: Sander Herfst; Judith van den Brand; E J A Schrauwen; Elzo de Wit; Vincent J Munster; Geert van Amerongen; M Linster; F Zaaraoui; Wilfred F J van Ijcken; Guus F Rimmelzwaan; A D M E Osterhaus; Ron A M Fouchier; A C Andeweg; Thijs Kuiken
Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques.
Veterinary pathology 2010;47(6):1040-7.
2010: Berend Jan Bosch; Rogier Bodewes; Robert P de Vries; Joost H C M Kreijtz; Willem Bartelink; Geert van Amerongen; Guus F Rimmelzwaan; Cornelis de Haan; Albert D M E Osterhaus; Peter J M Rottier
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets.
Journal of virology 2010;84(19):10366-74.
2010: Juthatip Keawcharoen; Monique I J Spronken; O Vuong; Theo M Bestebroer; Vincent J Munster; A D M E Osterhaus; Guus F Rimmelzwaan; Ron A M Fouchier
Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses.
Vaccine 2010;28(36):5803-9.
2010: Vincent J Munster; Eefje J A Schrauwen; Emmie de Wit; Judith van den Brand; Theo M Bestebroer; Sander Herfst; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Insertion of a multibasic cleavage motif into the hemagglutinin of a low-pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype.
Journal of virology 2010;84(16):7953-60.
2010: R Bodewes; J H C M Kreijtz; Geert van Amerongen; Martina M Geelhoed-Mieras; R J Verburgh; J G M Heldens; J Bedwell; Judith van den Brand; Thijs Kuiken; Carel A van Baalen; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets.
Journal of virology 2010;84(16):7943-52.
2010: Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska
Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(28):12599-604.
2010: Salin Chutinimitkul; Debby van Riel; Vincent J Munster; Judith van den Brand; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Ron A M Fouchier; Emmie de Wit
In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity.
Journal of virology 2010;84(13):6825-33.
2010: Rogier Bodewes; Joost H C M Kreijtz; Marine L B Hillaire; Martina M Geelhoed-Mieras; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
The Journal of general virology 2010;91(Pt 7):1743-53.
2010: Judith van den Brand; Koert J Stittelaar; Geert van Amerongen; Guus F Rimmelzwaan; James Simon; Emmie de Wit; Vincent J Munster; Theo Bestebroer; Ron A M Fouchier; Thijs Kuiken; Albert D M E Osterhaus
Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus.
The Journal of infectious diseases 2010;201(7):993-9.
2010: Debby van Riel; Michael A Den Bakker; Lonneke M E Leijten; Salin Chutinimitkul; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses.
The American journal of pathology 2010;176(4):1614-8.
2010: Sander Herfst; Salin Chutinimitkul; Jianqiang Ye; Emmie de Wit; Vincent J Munster; Eefje J A Schrauwen; Theo M Bestebroer; Marcel Jonges; Adam Meijer; Marion Koopmans; Guus F Rimmelzwaan; Albert D M E Osterhaus; Daniel R Perez; Ron A M Fouchier
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission.
Journal of virology 2010;84(8):3752-8.
2010: Emmie de Wit; Vincent J Munster; Debby van Riel; Walter Emil Philipp Beyer; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Ron A M Fouchier
Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host.
Journal of virology 2010;84(3):1597-606.
2010: Rogier Bodewes; Albert D M E Osterhaus; Guus F Rimmelzwaan
Targets for the induction of protective immunity against influenza a viruses.
Viruses 2010;2(1):166-88.
2010: Rogier Bodewes; Guus F Rimmelzwaan; Albert D M E Osterhaus
Animal models for the preclinical evaluation of candidate influenza vaccines.
Expert review of vaccines 2010;9(1):59-72.
2009: Rogier Bodewes; Joost H C M Kreijtz; Guus F Rimmelzwaan
Yearly influenza vaccinations: a double-edged sword?
The Lancet infectious diseases 2009;9(12):784-8.
2009: R Bodewes; Martina M Geelhoed-Mieras; J G M Heldens; J Glover; Bart N Lambrecht; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro.
Vaccine 2009;27(49):6833-9.
2009: Corine Geurtsvankessel; Monique Willart; Ingrid M Bergen; Leonie S van Rijt; Femke Muskens; Dirk Elewaut; Albert D M E Osterhaus; Rudolf W Hendriks; Guus F Rimmelzwaan; Bart N Lambrecht
Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice.
The Journal of experimental medicine 2009;206(11):2339-49.
2009: Guus F Rimmelzwaan; Joost H C M Kreijtz; Rogier Bodewes; Ron A M Fouchier; Albert D M E Osterhaus
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
Vaccine 2009;27(45):6363-5.
2009: J H C M Kreijtz; Yasemin Suezer; Gerrie de Mutsert; Judith van den Brand; Geert van Amerongen; Barbara S Schnierle; Thijs Kuiken; Ron A M Fouchier; Johannes Löwer; A D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
Vaccine 2009;27(45):6296-9.
2009: Anna L de Goede; Patrick H M Boers; Lennard Dekker; Albert D M E Osterhaus; Rob A Gruters; Guus F Rimmelzwaan
Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag.
Vaccine 2009;27(42):5735-9.
2009: J H C M Kreijtz; R Bodewes; Judith van den Brand; Gerrie de Mutsert; C Baas; Geert van Amerongen; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
Vaccine 2009;27(36):4983-9.
2009: Tomasz P Rygiel; Eva S K Rijkers; Talitha Eshuis - de Ruiter; Ellen H Stolte; Martin van der Valk; Guus F Rimmelzwaan; Louis Boon; Anton M van Loon; Frank E J Coenjaerts; Robert M Hoek; kiki tesselaar; Linde Meyaard
Lack of CD200 enhances pathological T cell responses during influenza infection.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(3):1990-6.
2009: Vincent J Munster; Emmie de Wit; Judith van den Brand; Sander Herfst; Eefje J A Schrauwen; Theo M Bestebroer; David van de Vijver; Charles A Boucher; Marion Koopmans; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Ron A M Fouchier
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.
Science (New York, N.Y.) 2009;325(5939):481-3.
2009: Leslie Reperant; Guus F Rimmelzwaan; Thijs Kuiken
Avian influenza viruses in mammals.
Revue scientifique et technique (International Office of Epizootics) 2009;28(1):137-59.
2009: Guus F Rimmelzwaan; Gerd Sutter
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.
Expert review of vaccines 2009;8(4):447-54.
2009: Vincent J Munster; Chantal Baas; Pascal Lexmond; Theo M Bestebroer; Judith Guldemeester; Walter Emil Philipp Beyer; Emmie de Wit; Martin Schutten; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests.
Journal of clinical microbiology 2009;47(3):666-73.
2009: Joost H C M Kreijtz; Albert D M E Osterhaus; Guus F Rimmelzwaan
Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
Human vaccines 2009;5(3):126-35.
2009: J H C M Kreijtz; Yasemin Suezer; G de Mutsert; Judith van den Brand; G van Amerongen; Barbara S Schnierle; Thijs Kuiken; Ron A M Fouchier; Johannes Löwer; A D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
The Journal of infectious diseases 2009;199(3):405-13.
2009: Willem Huisman; Byron Martina; Guus F Rimmelzwaan; Rob A Gruters; A D M E Osterhaus
Vaccine-induced enhancement of viral infections.
Vaccine 2009;27(4):505-12.
2009: Joost H C M Kreijtz; Yasemin Suezer; Gerrie de Mutsert; Geert van Amerongen; Astrid Schwantes; Judith van den Brand; Ron A M Fouchier; Johannes Löwer; Albert D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
PloS one 2009;4(11):e7790.
2009: Corine H GeurtsvanKessel; Ingrid M Bergen; Femke Muskens; Louis Boon; Henk C Hoogsteden; Albert D M E Osterhaus; Guus F Rimmelzwaan; Bart N Lambrecht
Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection.
PloS one 2009;4(9):e7187.
2009: Rogier Bodewes; Joost H C M Kreijtz; Chantal Baas; Martina M Geelhoed-Mieras; Gerrie de Mutsert; Geert van Amerongen; Judith van den Brand; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.
PloS one 2009;4(5):e5538.
2008: Willem Huisman; Eefje J A Schrauwen; Edwin Tijhaar; Yasemin Süzer; Suzan D Pas; Geert van Amerongen; Gerd Sutter; Guus F Rimmelzwaan; Albert D M E Osterhaus
Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Veterinary immunology and immunopathology 2008;126(3-4):332-8.
2008: Leslie Reperant; Geert van Amerongen; M W G van de Bildt; Guus F Rimmelzwaan; Andrew P Dobson; Albert D M E Osterhaus; Thijs Kuiken
Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses.
Emerging infectious diseases 2008;14(12):1835-41.
2008: Carel A van Baalen; Rob A Gruters; Eufemia G M Berkhoff; Albert D M E Osterhaus; Guus F Rimmelzwaan
FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2008;73(11):1058-65.
2008: Willem Huisman; Eefje J A Schrauwen; Guus F Rimmelzwaan; Albert D M E Osterhaus
Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus.
Virus research 2008;137(1):24-32.
2008: Guus F Rimmelzwaan; Janet E McElhaney
Correlates of protection: novel generations of influenza vaccines.
Vaccine 2008;26 Suppl 4():D41-4.
2008: Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.
Vaccine 2008;26 Suppl 4():D31-4.
2008: Tjitske de Boer; Jaap T van Dissel; Taco W J Kuijpers; Guus F Rimmelzwaan; Frank P Kroon; Tom H M Ottenhoff
Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I.
Clinical and vaccine immunology : CVI 2008;15(8):1171-5.
2008: Corine Geurtsvankessel; Monique Willart; Leonie S van Rijt; Femke Muskens; Mirjam Kool; Chantal Baas; Kris Thielemans; Clare Bennett; Björn E Clausen; Henk C Hoogsteden; Albert D M E Osterhaus; Guus F Rimmelzwaan; Bart N Lambrecht
Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells.
The Journal of experimental medicine 2008;205(7):1621-34.
2008: Fanny LeBouder; Eric Morello; Guus F Rimmelzwaan; Françoise Bosse; Christine Péchoux; Bernard Delmas; Béatrice Riteau
Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin.
Journal of virology 2008;82(14):6820-8.
2008: Byron Martina; Penelope Koraka; Petra van den Doel; Guus F Rimmelzwaan; Bart L Haagmans; Albert D M E Osterhaus
DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
Virus research 2008;135(1):64-71.
2008: J H C M Kreijtz; Gerrie de Mutsert; Carel A van Baalen; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.
Journal of virology 2008;82(11):5161-6.
2008: Willem Huisman; Eefje J A Schrauwen; Suzan D Pas; Geert van Amerongen; Guus F Rimmelzwaan; Albert D M E Osterhaus
Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats.
Vaccine 2008;26(21):2553-61.
2008: Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
The global circulation of seasonal influenza A (H3N2) viruses.
Science (New York, N.Y.) 2008;320(5874):340-6.
2008: Byron Martina; Penelope Koraka; Petra van den Doel; Geert van Amerongen; Guus F Rimmelzwaan; Albert D M E Osterhaus
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
Vaccine 2008;26(2):153-7.
2008: Tymen T Keller; Jelger J van der Meer; Peter Teeling; Koenraad F van der Sluijs; Mirza M Idu; Guus F Rimmelzwaan; Marcel Levi; Allard C van der Wal; Onno J de Boer
Selective expansion of influenza A virus-specific T cells in symptomatic human carotid artery atherosclerotic plaques.
Stroke; a journal of cerebral circulation 2008;39(1):174-9.
2007: Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus
Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.
Current opinion in biotechnology 2007;18(6):529-36.
2007: Guus F Rimmelzwaan; Nella J Nieuwkoop; Gerrie de Mutsert; A C M Boon; Thijs Kuiken; Ron A M Fouchier; Albert D M E Osterhaus
Attachment of infectious influenza A viruses of various subtypes to live mammalian and avian cells as measured by flow cytometry.
Virus research 2007;129(2):175-81.
2007: Debby van Riel; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals.
The American journal of pathology 2007;171(4):1215-23.
2007: Vincent J Munster; Emmie de Wit; Debby van Riel; Walter Emil Philipp Beyer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Thijs Kuiken; Ron A M Fouchier
The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses.
The Journal of infectious diseases 2007;196(2):258-65.
2007: Joost H C M Kreijtz; Yasemin Suezer; Geert van Amerongen; Gerrie de Mutsert; Barbara S Schnierle; John M Wood; Thijs Kuiken; Ron A M Fouchier; Johannes Lower; Albert D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
The Journal of infectious diseases 2007;195(11):1598-606.
2007: E G M Berkhoff; Martina M Geelhoed-Mieras; Marcel Jonges; Derek J Smith; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
An amino acid substitution in the influenza A virus hemagglutinin associated with escape from recognition by human virus-specific CD4+ T-cells.
Virus research 2007;126(1-2):282-7.
2007: Vincent J Munster; Chantal Baas; Pascal Lexmond; Jonas Waldenström; Anders Wallensten; Thord Fransson; Guus F Rimmelzwaan; Walter Emil Philipp Beyer; Martin Schutten; Björn Olsen; Albert D M E Osterhaus; Ron A M Fouchier
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds.
PLoS pathogens 2007;3(5):e61.
2007: E G M Berkhoff; Martina M Geelhoed-Mieras; Esther J Verschuren; Carel A van Baalen; Rob A Gruters; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.
Clinical and experimental immunology 2007;148(2):296-306.
2007: Emmie de Wit; Monique I J Spronken; Gaby Vervaet; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
A reverse-genetics system for Influenza A virus using T7 RNA polymerase.
The Journal of general virology 2007;88(Pt 4):1281-7.
2007: Jan C de Jong; Derek J Smith; Alan S Lapedes; Isabella Donatelli; Laura Campitelli; Giuseppe Barigazzi; K Van Reeth; T C Jones; Guus F Rimmelzwaan; A D M E Osterhaus; Ron A M Fouchier
Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.
Journal of virology 2007;81(8):4315-22.
2007: E G M Berkhoff; Martina M Geelhoed-Mieras; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.
The Journal of general virology 2007;88(Pt 2):530-5.
2007: J H C M Kreijtz; R Bodewes; Geert van Amerongen; Thijs Kuiken; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
Vaccine 2007;25(4):612-20.
2007: Emmie de Wit; Theo M Bestebroer; Monique I J Spronken; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Rapid sequencing of the non-coding regions of influenza A virus.
Journal of virological methods 2007;139(1):85-9.
2006: E G M Berkhoff; Emmie de Wit; Martina M Geelhoed-Mieras; A C M Boon; Jori Symons; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses.
Vaccine 2006;24(44-46):6594-6.
2006: Emmie de Wit; Monique I J Spronken; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene.
Vaccine 2006;24(44-46):6647-50.
2006: Guus F Rimmelzwaan; Jan C de Jong; G A Donker; Adam Meijer; Ron A M Fouchier; A D M E Osterhaus
[The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].
Nederlands tijdschrift voor geneeskunde 2006;150(40):2209-14.
2006: Marie Paule Kieny; Alejandro Costa; Joachim Hombach; Peter Carrasco; Yuri Pervikov; David Salisbury; Michel Greco; Ian Gust; Marc LaForce; carlos franco-paredes; José Ignacio Santos; Eric D'Hondt; Guus F Rimmelzwaan; Ruth A Karron; Keiji Fukuda
A global pandemic influenza vaccine action plan.
Vaccine 2006;24(40-41):6367-70.
2006: A C M Boon; Gerrie de Mutsert; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
Journal of virology 2006;80(12):6024-32.
2006: Thijs Kuiken; Edward C Holmes; John McCauley; Guus F Rimmelzwaan; Catherine S Williams; Bryan T Grenfell
Host species barriers to influenza virus infections.
Science (New York, N.Y.) 2006;312(5772):394-7.
2006: Debby van Riel; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Ab D M E Osterhaus; Thijs Kuiken
H5N1 Virus Attachment to Lower Respiratory Tract.
Science (New York, N.Y.) 2006;312(5772):399.
2006: Thijs Kuiken; Ron A M Fouchier; Guus F Rimmelzwaan; Albert Osterhaus; Peter Roeder
Feline friend or potential foe?
Nature 2006;440(7085):741-2.
2006: Mireille Toebes; Miriam Coccoris; Adriaan Bins; Boris Rodenko; Raquel Gomez; Nella J Nieuwkoop; Willeke van de Kasteele; Guus F Rimmelzwaan; John B A G Haanen; Huib Ovaa; Schumacher Ton
Design and use of conditional MHC class I ligands.
Nature medicine 2006;12(2):246-51.
2006: Guus F Rimmelzwaan; Debby van Riel; Marianne Baars; Theo M Bestebroer; Geert van Amerongen; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts.
The American journal of pathology 2006;168(1):176-83; quiz 364.
2005: Jan C de Jong; Guus F Rimmelzwaan; Aad I M Bartelds; Adam Meijer; Ron A M Fouchier; A D M E Osterhaus
[The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
Nederlands tijdschrift voor geneeskunde 2005;149(42):2355-61.
2005: Vincent J Munster; Anders Wallensten; Chantal Baas; Guus F Rimmelzwaan; Martin Schutten; Björn Olsen; Albert D M E Osterhaus; Ron A M Fouchier
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe.
Emerging infectious diseases 2005;11(10):1545-51.
2005: A C M Boon; Gerrie de Mutsert; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity.
Clinical and experimental immunology 2005;142(1):45-52.
2005: Emmie de Wit; Vincent J Munster; Monique I J Spronken; Theo M Bestebroer; Chantal Baas; Walter Emil Philipp Beyer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
Journal of virology 2005;79(19):12401-7.
2005: Carel A van Baalen; David Kwa; Esther J Verschuren; Mariska L Reedijk; A C M Boon; Gerrie de Mutsert; Guus F Rimmelzwaan; Albert D M E Osterhaus; Rob A Gruters
Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.
The Journal of infectious diseases 2005;192(7):1183-90.
2005: E G M Berkhoff; Emmie de Wit; Martina M Geelhoed-Mieras; A C M Boon; Jori Symons; Ron A M Fouchier; A D M E Osterhaus; Guus F Rimmelzwaan
Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.
Journal of virology 2005;79(17):11239-46.
2005: Guus F Rimmelzwaan; E G M Berkhoff; Nella J Nieuwkoop; Derek J Smith; Ron A M Fouchier; A D M E Osterhaus
Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants.
The Journal of general virology 2005;86(Pt 6):1801-5.
2005: Ron A M Fouchier; Thijs Kuiken; Guus F Rimmelzwaan; Albert Osterhaus
Global task force for influenza.
Nature 2005;435(7041):419-20.
2005: Ron Am Fouchier; Guus F Rimmelzwaan; Thijs Kuiken; Albert Dme Osterhaus
Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses.
Current opinion in infectious diseases 2005;18(2):141-6.
2005: Ron A M Fouchier; Vincent J Munster; Anders Wallensten; Theo M Bestebroer; Sander Herfst; Derek Smith; Guus F Rimmelzwaan; Björn Olsen; Albert D M E Osterhaus
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.
Journal of virology 2005;79(5):2814-22.
2004: Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Terry C Jones; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Mutations, drift, and the influenza archipelago.
Discovery medicine 2004;4(24):371-7.
2004: Herman J Bueving; Johannes C van der Wouden; Hein Raat; Roos M D Bernsen; Johan C de Jongste; Lisette W A van Suijlekom-Smit; A D M E Osterhaus; Guus F Rimmelzwaan; M Rutten-van Mölken; Siep Thomas
Influenza vaccination in asthmatic children: effects on quality of life and symptoms.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;24(6):925-31.
2004: Herman J Bueving; Roos M D Bernsen; Johan C de Jongste; Lisette W A van Suijlekom-Smit; Guus F Rimmelzwaan; Albert D M E Osterhaus; Maureen P M H Rutten-Van Mölken; Siep Thomas; Johannes C van der Wouden
Does influenza vaccination exacerbate asthma in children?
Vaccine 2004;23(1):91-6.
2004: Thijs Kuiken; Guus F Rimmelzwaan; Debby van Riel; Geert van Amerongen; Marianne Baars; Ron A M Fouchier; Albert Osterhaus
Avian H5N1 influenza in cats.
Science (New York, N.Y.) 2004;306(5694):241.
2004: Guus F Rimmelzwaan; Jan C de Jong; Aad I M Bartelds; berry wilbrink; Ron A M Fouchier; A D M E Osterhaus
[The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season].
Nederlands tijdschrift voor geneeskunde 2004;148(40):1984-8.
2004: Guus F Rimmelzwaan; E G M Berkhoff; Nella J Nieuwkoop; Ron A M Fouchier; A D M E Osterhaus
Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza a viruses by comutations.
Journal of virology 2004;78(16):8946-9.
2004: Guus F Rimmelzwaan; A C M Boon; Martina M Geelhoed-Mieras; J T M Voeten; Ron A M Fouchier; A D M E Osterhaus
Human airway epithelial cells present antigen to influenza virus-specific CD8+ CTL inefficiently after incubation with viral protein together with ISCOMATRIX.
Vaccine 2004;22(21-22):2769-75.
2004: Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Mapping the antigenic and genetic evolution of influenza virus.
Science (New York, N.Y.) 2004;305(5682):371-6.
2004: Willem Huisman; Eefje J A Schrauwen; Suzan D Pas; Jos A Karlas; Guus F Rimmelzwaan; Albert D M E Osterhaus
Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats.
The Journal of general virology 2004;85(Pt 7):1833-41.
2004: Emmie de Wit; Monique I J Spronken; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments.
Virus research 2004;103(1-2):155-61.
2004: Guus F Rimmelzwaan; A C M Boon; J T M Voeten; E G M Berkhoff; Ron A M Fouchier; A D M E Osterhaus
Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Virus research 2004;103(1-2):97-100.
2004: E G M Berkhoff; A C M Boon; Nella J Nieuwkoop; Ron A M Fouchier; Kees Sintnicolaas; A D M E Osterhaus; Guus F Rimmelzwaan
A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.
Journal of virology 2004;78(10):5216-22.
2004: A C M Boon; Gerrie de Mutsert; Ron A M Fouchier; Kees Sintnicolaas; Albert D M E Osterhaus; Guus F Rimmelzwaan
Preferential HLA usage in the influenza virus-specific CTL response.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(7):4435-43.
2004: A C M Boon; S Plotkin; Guus F Rimmelzwaan; A D M E Osterhaus
Viral vaccine meeting held in Barcelona, October 25-28, 2003.
Vaccine 2004;22(11-12):1327-34.
2004: Bart L Haagmans; Thijs Kuiken; Byron Martina; Ron A M Fouchier; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Ton de Jong; Shigeyuki Itamura; Kwok-Hung Chan; Masato Tashiro; Albert D M E Osterhaus
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
Nature medicine 2004;10(3):290-3.
2004: A C M Boon; Gerrie de Mutsert; Debbie Van Baarle; Derek J Smith; Alan S Lapedes; Ron A M Fouchier; Kees Sintnicolaas; Albert D M E Osterhaus; Guus F Rimmelzwaan
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(4):2453-60.
2004: Herman J Bueving; Roos M D Bernsen; Johan C de Jongste; Lisette W A van Suijlekom-Smit; Guus F Rimmelzwaan; Albert D M E Osterhaus; Maureen P M H Rutten-Van Mölken; Siep Thomas; Johannes C van der Wouden
Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial.
American journal of respiratory and critical care medicine 2004;169(4):488-93.
2004: Ron A M Fouchier; Peter M Schneeberger; Frans W Rozendaal; Jan M Broekman; Stiena A G Kemink; Vincent J Munster; Thijs Kuiken; Guus F Rimmelzwaan; Martin Schutten; G J J van Doornum; Guus Koch; Arnold Bosman; Marion Koopmans; Albert D M E Osterhaus
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(5):1356-61.
2004: Jan C de Jong; Walter Emil Philipp Beyer; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus
[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
Nederlands tijdschrift voor geneeskunde 2004;148(2):73-9.
2003: Thijs Kuiken; Ron A M Fouchier; Guus F Rimmelzwaan; Albert Osterhaus
Emerging viral infections in a rapidly changing world.
Current opinion in biotechnology 2003;14(6):641-6.
2003: Byron Martina; Bart L Haagmans; Thijs Kuiken; Ron A M Fouchier; Guus F Rimmelzwaan; Geert van Amerongen; J S M Peiris; Wilina Lim; Albert D M E Osterhaus
Virology: SARS virus infection of cats and ferrets.
Nature 2003;425(6961):915.
2003: Jan C de Jong; Guus F Rimmelzwaan; Aad I M Bartelds; berry wilbrink; Ron A M Fouchier; Albert D M E Osterhaus
[The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season].
Nederlands tijdschrift voor geneeskunde 2003;147(40):1971-5.
2003: Julia R Gog; Guus F Rimmelzwaan; Albert D M E Osterhaus; Bryan T Grenfell
Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):11143-7.
2003: Thijs Kuiken; Ron A M Fouchier; Martin Schutten; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Jon D Laman; Ton de Jong; G J J van Doornum; Wilina Lim; Ai Ee Ling; Paul K S Chan; John S Tam; Maria C Zambon; Robin Gopal; Christian Drosten; Sylvie van der Werf; Nicolas Escriou; Jean-Claude Manuguerra; Klaus Stöhr; J S M Peiris; Albert D M E Osterhaus
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.
Lancet 2003;362(9380):263-70.
2003: Thijs Kuiken; Guus F Rimmelzwaan; Geert van Amerongen; A D M E Osterhaus
Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis).
Veterinary pathology 2003;40(3):304-10.
2003: Jan C de Jong; Abraham M Palache; Walter Emil Philipp Beyer; Guus F Rimmelzwaan; A C M Boon; A D M E Osterhaus
Haemagglutination-inhibiting antibody to influenza virus.
Developments in biologicals 2003;115():63-73.
2003: Guus F Rimmelzwaan; Thijs Kuiken; Geert van Amerongen; Theo M Bestebroer; Ron A M Fouchier; A D M E Osterhaus
A primate model to study the pathogenesis of influenza A (H5N1) virus infection.
Avian diseases 2003;47(3 Suppl):931-3.
2003: Ron A M Fouchier; Björn Olsen; Theo M Bestebroer; Sander Herfst; L van der Kemp; Guus F Rimmelzwaan; A D M E Osterhaus
Influenza A virus surveillance in wild birds in Northern Europe in 1999 and 2000.
Avian diseases 2003;47(3 Suppl):857-60.
2002: Guus F Rimmelzwaan; Jan C de Jong; Aad I M Bartelds; berry wilbrink; Ron A M Fouchier; A D M E Osterhaus
[The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season].
Nederlands tijdschrift voor geneeskunde 2002;146(39):1846-50.
2002: Wendeline Wouters-Wesseling; Marja Rozendaal; Marieke Snijder; Yvo Graus; Guus F Rimmelzwaan; Lisette C P G M de Groot; Jacques G Bindels
Effect of a complete nutritional supplement on antibody response to influenza vaccine in elderly people.
The journals of gerontology. Series A, Biological sciences and medical sciences 2002;57(9):M563-6.
2002: A C M Boon; E Fringuelli; Y M F Graus; Ron A M Fouchier; Kees Sintnicolaas; Alfonso Iorio; Guus F Rimmelzwaan; A D M E Osterhaus
Influenza A virus specific T cell immunity in humans during aging.
Virology 2002;299(1):100-8.
2002: A D M E Osterhaus; Jan C de Jong; Guus F Rimmelzwaan; Eric C J Claas
H5N1 influenza in Hong Kong: virus characterizations.
Vaccine 2002;20 Suppl 2():S82-3.
2002: Karl Ljungberg; Camilla Kolmskog; Britta Wahren; Geert van Amerongen; Marianne Baars; Albert Osterhaus; Annika Linde; Guus F Rimmelzwaan
DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes.
Vaccine 2002;20(16):2045-52.
2002: A C M Boon; Gerrie de Mutsert; Y M F Graus; Ron A M Fouchier; Kees Sintnicolaas; A D M E Osterhaus; Guus F Rimmelzwaan
Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Journal of virology 2002;76(5):2567-72.
2002: A C M Boon; Arjan Paul Vos; Y M F Graus; Guus F Rimmelzwaan; A D M E Osterhaus
In vitro effect of bioactive compounds on influenza virus specific B- and T-cell responses.
Scandinavian journal of immunology 2002;55(1):24-32.
2002: A C M Boon; Gerrie de Mutsert; Y M F Graus; Ron A M Fouchier; Kees Sintnicolaas; A D M E Osterhaus; Guus F Rimmelzwaan
The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
Journal of virology 2002;76(2):582-90.
2001: Guus F Rimmelzwaan; Marianne Baars; Geert van Amerongen; R H T Van Beek; Albert D M E Osterhaus
A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses.
Vaccine 2001;20(1-2):158-63.
2001: Jan C de Jong; Guus F Rimmelzwaan; Aad I M Bartelds; berry wilbrink; Ron A M Fouchier; Albert D M E Osterhaus
[2000/01 influenza season and the vaccine composition for the season 2001/'02].
Nederlands tijdschrift voor geneeskunde 2001;145(40):1945-50.
2001: J T M Voeten; Guus F Rimmelzwaan; Nella J Nieuwkoop; Ron A M Fouchier; Albert D M E Osterhaus
Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.
Clinical and experimental immunology 2001;125(3):423-31.
2001: Jan C de Jong; Paul P Heinen; W L A Loeffen; AP van Nieuwstadt; E C Claas; Theo M Bestebroer; K Bijlsma; C Verweij; Albert D M E Osterhaus; Guus F Rimmelzwaan; Ron A M Fouchier; Tjeerd G Kimman
Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy.
Vaccine 2001;19(31):4452-64.
2001: Guus F Rimmelzwaan; Thijs Kuiken; Geert van Amerongen; Theo M Bestebroer; Ron A M Fouchier; Albert D M E Osterhaus
Pathogenesis of influenza A (H5N1) virus infection in a primate model.
Journal of virology 2001;75(14):6687-91.
2001: Guus F Rimmelzwaan; Jan C de Jong; Theo M Bestebroer; Anton M van Loon; E C Claas; Ron A M Fouchier; Albert D M E Osterhaus
Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands.
Virology 2001;282(2):301-6.
2000: Guus F Rimmelzwaan; Nella J Nieuwkoop; AH Brandenburg; G Sutter; Walter Emil Philipp Beyer; D Maher; J Bates; Albert D M E Osterhaus
A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.
Vaccine 2000;19(9-10):1180-7.
2000: Ron A M Fouchier; Theo M Bestebroer; Sander Herfst; L Van Der Kemp; Guus F Rimmelzwaan; Albert D M E Osterhaus
Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene.
Journal of clinical microbiology 2000;38(11):4096-101.
2000: J T M Voeten; Guus F Rimmelzwaan; Nella J Nieuwkoop; K Lövgren-Bengtsson; Albert D M E Osterhaus
Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes.
Vaccine 2000;19(4-5):514-22.
2000: J T M Voeten; Theo M Bestebroer; Nella J Nieuwkoop; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.
Journal of virology 2000;74(15):6800-7.
2000: Albert D M E Osterhaus; Guus F Rimmelzwaan; Byron Martina; Theo M Bestebroer; Ron A M Fouchier
Influenza B virus in seals.
Science (New York, N.Y.) 2000;288(5468):1051-3.
2000: Jan C de Jong; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus
Influenza virus: a master of metamorphosis.
The Journal of infection 2000;40(3):218-28.
2000: Jan C de Jong; Walter Emil Philipp Beyer; Abraham M Palache; Guus F Rimmelzwaan; Albert D M E Osterhaus
Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
Journal of medical virology 2000;61(1):94-9.
2000: N M Soesman; Guus F Rimmelzwaan; Nella J Nieuwkoop; Walter Emil Philipp Beyer; H W Tilanus; M H Kemmeren; Herold J Metselaar; Robert A de Man; Albert D M E Osterhaus
Efficacy of influenza vaccination in adult liver transplant recipients.
Journal of medical virology 2000;61(1):85-93.
1999: Guus F Rimmelzwaan; Marianne Baars; P de Lijster; Ron A M Fouchier; Albert D M E Osterhaus
Inhibition of influenza virus replication by nitric oxide.
Journal of virology 1999;73(10):8880-3.
1999: Guus F Rimmelzwaan; Marianne Baars; R H T Van Beek; P de Lijster; Jan C de Jong; Eric C J Claas; Albert D M E Osterhaus
Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine.
Vaccine 1999;17(20-21):2512-6.
1999: J T M Voeten; R Brands; Abraham M Palache; GJ van Scharrenburg; Guus F Rimmelzwaan; Albert D M E Osterhaus; Eric C J Claas
Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium.
Vaccine 1999;17(15-16):1942-50.
1999: Guus F Rimmelzwaan; Eric C J Claas; Geert van Amerongen; Jan C de Jong; Albert D M E Osterhaus
ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.
Vaccine 1999;17(11-12):1355-8.
1999: Jos A Karlas; KH Siebelink; M A Peer; Willem Huisman; A M Cuisinier; Guus F Rimmelzwaan; Albert D M E Osterhaus
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection.
The Journal of general virology 1999;80 ( Pt 3)():761-5.
1999: J T M Voeten; Eric C J Claas; R Brands; Abraham M Palache; GJ van Scharrenburg; Guus F Rimmelzwaan; Albert D M E Osterhaus
Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells.
Developments in biological standardization 1999;98():77-87; discussion 89-90.
1998: J T M Voeten; Jan Groen; D van Alphen; Eric C J Claas; Ronald de Groot; Albert D M E Osterhaus; Guus F Rimmelzwaan
Use of recombinant nucleoproteins in enzyme-linked immunosorbent assays for detection of virus-specific immunoglobulin A (IgA) and IgG antibodies in influenza virus A- or B-infected patients.
Journal of clinical microbiology 1998;36(12):3527-31.
1998: Jos A Karlas; KH Siebelink; M A v Peer; Willem Huisman; Guus F Rimmelzwaan; Albert D M E Osterhaus
Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells.
Veterinary immunology and immunopathology 1998;65(2-4):353-65.
1998: Guus F Rimmelzwaan; Marianne Baars; Eric C J Claas; Albert D M E Osterhaus
Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro.
Journal of virological methods 1998;74(1):57-66.
1998: Eric C J Claas; Jan C de Jong; R H T Van Beek; Guus F Rimmelzwaan; Albert D M E Osterhaus
Human influenza virus A/HongKong/156/97 (H5N1) infection.
Vaccine 1998;16(9-10):977-8.
1998: Eric C J Claas; Albert D M E Osterhaus; R H T Van Beek; Jan C de Jong; Guus F Rimmelzwaan; Dennis A Senne; S Krauss; Kennedy F Shortridge; R G Webster
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.
Lancet 1998;351(9101):472-7.
1998: Willem Huisman; Jos A Karlas; KH Siebelink; RC Huisman; A de Ronde; M J Francis; Guus F Rimmelzwaan; Albert D M E Osterhaus
Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
Vaccine 1998;16(2-3):181-7.
1998: Albert D M E Osterhaus; Guus F Rimmelzwaan
Induction of virus-specific immunity by iscoms.
Developments in biological standardization 1998;92():49-58.
1997: Guus F Rimmelzwaan; Marianne Baars; R H T Van Beek; Geert van Amerongen; K Lövgren-Bengtsson; Eric C J Claas; Albert D M E Osterhaus
Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.
The Journal of general virology 1997;78 ( Pt 4)():757-65.